https://www.selleckchem.com/pr....oducts/Aurora-A-Inhi
sHGA decreased to values around the lower limit of quantitation. There was sustained tyrosinaemia after four weeks of nitisinone therapy with significant fluctuations over the day in individual patients. Diet and degree of conversion of HPPA to HPLA may determine extent of nitisinone-induced tyrosinaemia. A fasting blood sample is recommended to monitor sTYR during nitisinone therapy Adaptations in HPPA metabolites as well as the inhibition of tyrosine aminotransferase could be contributing factors generating tyrosinaemia d
Curtir
Comentario
Compartilhar
